Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 922† | 778† | 644† | 523† | 473† |
| Net profit | 66 | 61 | 58 | 43 | 39† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| ASHOK KUMAR WINDLASS | Executive Director | June 30, 2026 |
| HITESH WINDLASS | Executive Director | June 30, 2026 |
| MANOJ KUMAR WINDLASS | Executive Director | June 30, 2026 |
| PAWAN KUMAR SHARMA | Executive Director | June 30, 2026 |
| GAURAV GULATI | Independent Director | June 30, 2026 |
| TARASHREE SINGHAL | Independent Director | June 30, 2026 |
| VIVEK DHARIWAL | Independent Director | June 30, 2026 |
| PRACHI JAIN WINDLASS | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
